Not applicableTemporarily pausedNCT02607709What this trial is testingLymphadenectomy in Urothelial CarcinomaWho this might be right forUreteral Neoplasms Zealand University Hospital 366
Very early researchActive Not RecruitingNCT02812420What this trial is testingDurvalumab and Tremelimumab in Treating Patients With Muscle-Invasive, High-Risk Urothelial Cancer That Cannot Be Treated With Cisplatin-Based Therapy Before SurgeryWho this might be right forHydronephrosisInfiltrating Bladder Urothelial Carcinoma Sarcomatoid VariantInfiltrating Bladder Urothelial Carcinoma, Micropapillary Variant+16 more M.D. Anderson Cancer Center 54
Testing effectiveness (Phase 2)Study completedNCT00749892What this trial is testingErlotinib Hydrochloride in Treating Participants With Muscle Invasive or Recurrent Urothelial CancerWho this might be right forRecurrent Bladder Urothelial CarcinomaRecurrent Renal Pelvis Urothelial CarcinomaRecurrent Ureter Urothelial Carcinoma+17 more M.D. Anderson Cancer Center 34
Not applicableLooking for participantsNCT05874921What this trial is testingUTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With JelmytoWho this might be right forUrothelial CarcinomaUrothelial Carcinoma RecurrentUrothelial Carcinoma Ureter+5 more UroGen Pharma Ltd. 400
Testing effectiveness (Phase 2)Ended earlyNCT01353222What this trial is testingDN24-02 as Adjuvant Therapy in Subjects With High Risk HER2+ Urothelial CarcinomaWho this might be right forUrothelial Carcinoma Dendreon 142
Testing effectiveness (Phase 2)Study completedNCT00072150What this trial is testingPhase II Trial Of PS-341 (Bortezomib) In Patients With Previously Treated Advanced Urothelial Tract Transitional Cell CarcinomaWho this might be right forMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Bladder CancerRecurrent Transitional Cell Cancer of the Renal Pelvis and Ureter+7 more National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00397488What this trial is testingSunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Memorial Sloan Kettering Cancer Center 78
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07720921What this trial is testingNeoadjuvant Disitamab Vedotin, Toripalimab, and Radiotherapy for High-risk UTUC ( LUXUS07.1 )Who this might be right forUrothelial Carcinoma of the Renal Pelvis and UreterNeoadjuvant Therapy Peking University First Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT04871529What this trial is testingTesting the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)Who this might be right forBladder Carcinoma Infiltrating the Muscle of the Bladder WallInfiltrating Renal Pelvis and Ureter Urothelial CarcinomaStage II Bladder Cancer AJCC v8 SWOG Cancer Research Network 6
Large-scale testing (Phase 3)Study completedNCT00014274What this trial is testingCombination Chemotherapy in Treating Patients With Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer European Organisation for Research and Treatment of Cancer - EORTC 238
Testing effectiveness (Phase 2)Study completedNCT00004203What this trial is testingOxaliplatin in Treating Patients With Metastatic Bladder CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter University of Chicago 20
Testing effectiveness (Phase 2)Study completedNCT00014144What this trial is testingS0031, ZD 1839 in Treating Patients With Advanced Cancer of the Urinary TractWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer SWOG Cancer Research Network 31
Testing effectiveness (Phase 2)Study completedNCT00009867What this trial is testingArsenic Trioxide in Treating Patients With Urothelial CancerWho this might be right forRecurrent Transitional Cell Cancer of the Renal Pelvis and UreterRecurrent Urethral CancerTransitional Cell Carcinoma of the Bladder+1 more National Cancer Institute (NCI) 35
Early research (Phase 1)Study completedNCT00003133What this trial is testingCombination Chemotherapy Following Surgery in Treating Patients With Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT01090466What this trial is testingGemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the UrotheliumWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer Cardiff University 15
Testing effectiveness (Phase 2)Looking for participantsNCT06983210What this trial is testingClinical Trial of AM80 in Combination With Gemcitabine, Cisplatin, and Nivolumab in Patients With Urothelial CarcinomaWho this might be right forUrothelial Carcinoma BladderUrothelial Carcinoma of the Renal Pelvis and UreterUrothelial Carcinoma Urethra+1 more Nagoya University 43
Testing effectiveness (Phase 2)Study completedNCT00028860What this trial is testingCombination Chemotherapy Following Surgery in Treating Patients With Urinary Tract CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Tulane University Health Sciences Center
Early research (Phase 1)Active Not RecruitingNCT04620603What this trial is testingLow-Dose-Rate Brachytherapy Combined With Immune Checkpoint Inhibition in CancerWho this might be right forCutaneous Malignant MelanomaRenal Cell CancerUrothelial Cancer of Renal Pelvis Case Comprehensive Cancer Center 5
Large-scale testing (Phase 3)WithdrawnNCT04006691What this trial is testingEfficacy and Safety of UGN-101 in Recurrent PatientsWho this might be right forCarcinomaTransitional Cell CarcinomaTransitional Cell Cancer of the Renal Pelvis and Ureter UroGen Pharma Ltd.
Testing effectiveness (Phase 2)Study completedNCT00792025What this trial is testingSunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Institut Curie 80